ClearBridge Investments - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$427,869
-20.6%
15,900
-11.2%
0.00%
Q2 2023$538,969
-6.9%
17,9000.0%0.00%
-100.0%
Q1 2023$579,065
+12.7%
17,900
-0.1%
0.00%0.0%
Q4 2022$513,731
+131.4%
17,925
+209.1%
0.00%
Q1 2022$222,000
+6.2%
5,8000.0%0.00%
Q4 2020$209,000
-39.4%
5,800
-34.1%
0.00%
Q3 2020$345,000
+6.8%
8,8000.0%0.00%
Q2 2020$323,000
+29.7%
8,800
-18.5%
0.00%
Q1 2020$249,000
-21.5%
10,8000.0%0.00%
Q4 2019$317,000
+18.7%
10,800
+8.0%
0.00%
Q3 2019$267,000
-5.0%
10,000
-9.1%
0.00%
Q2 2019$281,000
+13.8%
11,0000.0%0.00%
Q1 2019$247,000
+6.5%
11,0000.0%0.00%
Q4 2018$232,000
+38.9%
11,000
+22.2%
0.00%
Q3 2018$167,000
-37.7%
9,000
-25.0%
0.00%
Q2 2018$268,000
+1.5%
12,0000.0%0.00%
Q1 2018$264,000
+473.9%
12,000
+500.0%
0.00%
Q4 2017$46,0000.0%2,0000.0%0.00%
Q3 2017$46,000
+4.5%
2,0000.0%0.00%
Q2 2017$44,000
-4.3%
2,0000.0%0.00%
Q1 2017$46,000
+9.5%
2,0000.0%0.00%
Q4 2016$42,000
-20.8%
2,0000.0%0.00%
Q3 2016$53,000
-3.6%
2,0000.0%0.00%
Q2 2016$55,0002,0000.00%
Other shareholders
VANECK VECTORS ETF TR shareholders Q1 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders